1. A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma
   Hongye Wang et al, 2020, Journal of Cancer Research and Therapeutics CrossRef
2. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
   Yi-Sheng Liu et al, 2018, BMC Gastroenterology CrossRef
3. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
   null null et al, 2020, BMC Cancer CrossRef
4. MRI‐Based Radiomics: Associations With the Recurrence‐Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization
   Wenlong Song et al, 2020, Journal of Magnetic Resonance Imaging CrossRef
5. Gadoxetic Acid-Enhanced MRI Features for Predicting Treatment Outcomes of Early Hepatocellular Carcinoma (< 3 cm) After Transarterial Chemoembolization
   Byung Chan Lee et al, 2022, Academic Radiology CrossRef
6. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE
   Bo Hu et al, 2020, CardioVascular and Interventional Radiology CrossRef
7. Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review
   Nisha Manjunatha et al, 2022, Cureus CrossRef
8. Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment
   Haiping Zhang et al, 2019, The British Journal of Radiology CrossRef
9. The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
   Hiroaki Takaya et al, 2021, Journal of Clinical Medicine CrossRef
10. Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa® and VIVA® Systems
    Hiroaki Takaya et al, 2022, Journal of Clinical Medicine CrossRef
11. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma
    Henrique A. Lima et al, 2022, Journal of Gastrointestinal Surgery CrossRef
12. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ye Sheng et al, 2023, Academic Radiology CrossRef
13. Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging
    Jieun Byun et al, 2021, Acta Radiologica CrossRef
14. Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Tim A. Labeur et al, 2019, CardioVascular and Interventional Radiology CrossRef